Immune Thrombocytopenic Purpura

What is immune thrombocytopenic purpura?

Immune thrombocytopenic purpura, often shortened to ITP, is a condition in which the body’s immune system mistakenly attacks and destroys platelets. Platelets are small blood cells that help the blood clot and stop bleeding after an injury. When platelet numbers fall too low, a person may bruise easily, bleed longer than usual, or develop small spots of bleeding under the skin. The word “thrombocytopenic” means a low platelet count, and “purpura” refers to the purple-colored patches that can appear on the skin when bleeding happens beneath its surface. In medical records, the condition is coded as ICD-10 D69.3. Many doctors now prefer the name “immune thrombocytopenia,” because visible purpura does not appear in every person with the condition.

So, what is immune thrombocytopenic purpura in everyday terms? It is essentially an autoimmune disorder — a condition in which the immune system, which normally protects the body from infections, turns against the body’s own healthy cells. In ITP, antibodies (proteins made by the immune system) attach to platelets and mark them for destruction, mainly in the spleen. The spleen is an organ in the upper left part of the abdomen that filters the blood. The immune attack may also reduce the bone marrow’s ability to make new platelets fast enough to replace those being lost.

ITP can affect people of any age. In children, it often appears suddenly, frequently within a few weeks after a viral infection, and in many cases it goes away on its own within a few months. In adults, the condition tends to develop more gradually and is more likely to become long-lasting, meaning it may need ongoing monitoring or treatment. ITP is generally divided into three phases: newly diagnosed (within the first three months), persistent (lasting three to twelve months), and chronic (lasting longer than twelve months). ITP is not contagious and is not a form of cancer.

Symptoms of immune thrombocytopenic purpura

Immune thrombocytopenic purpura symptoms are mostly related to bleeding, because platelets are the cells responsible for plugging small breaks in blood vessels. Some people, especially those with only a mildly reduced platelet count, have no symptoms at all, and the condition is discovered by chance during a routine blood test.

Common signs and symptoms include:

• Easy or excessive bruising — bruises (also called ecchymoses) may appear after minor bumps or seemingly without cause.
• Petechiae — tiny, pinpoint red or purple dots on the skin, often on the lower legs, caused by small amounts of bleeding under the skin. They may look like a rash but do not fade when pressed.
• Purpura — larger purple or reddish patches on the skin or inside the mouth, formed when petechiae cluster together or when bleeding under the skin is more extensive.
• Bleeding from the gums or nose — nosebleeds may be more frequent or harder to stop, and gums may bleed during tooth brushing.
• Prolonged bleeding from cuts — small wounds may ooze longer than expected.
• Blood in urine or stool — urine may look pink or red, and stool may look dark or tarry.
• Unusually heavy or prolonged menstrual periods in women and girls.
• Fatigue — many people with ITP report tiredness, although the reason for this is not fully understood.

Symptoms often relate to how low the platelet count is. People with a moderately reduced count may notice only occasional bruising, while those with a very low count are more likely to have spontaneous bleeding, such as nosebleeds or bleeding gums. Serious internal bleeding, including bleeding inside the skull, is uncommon but is the most dangerous complication and requires emergency care.

The pattern of symptoms can also differ by stage and type. In children with newly diagnosed ITP, bruising and petechiae often appear abruptly in an otherwise healthy child, sometimes shortly after a viral illness or, rarely, after certain vaccinations. In adults with chronic ITP, symptoms may come and go over months or years, with periods of relative stability interrupted by flare-ups when the platelet count drops. Because symptoms can fluctuate, doctors usually judge the seriousness of ITP based on both the platelet count and the actual bleeding a person experiences, not on the count alone.

Causes and risk factors

The exact trigger of immune thrombocytopenic purpura is often unknown. When no underlying condition is identified, doctors call it primary ITP. In primary ITP, the immune system produces antibodies that stick to the surface of platelets. The spleen then recognizes these antibody-coated platelets as abnormal and removes them from circulation faster than the bone marrow can replace them. Research also suggests the immune attack can affect megakaryocytes, the bone marrow cells that produce platelets, further lowering platelet production.

When ITP develops in connection with another condition or exposure, it is called secondary ITP. Recognized immune thrombocytopenic purpura causes and associations include:

• Viral infections — in children especially, ITP often follows common viral illnesses. Infections such as HIV, hepatitis C, and Epstein–Barr virus (the virus behind infectious mononucleosis) have also been linked to ITP in some people.
• Helicobacter pylori infection — a bacterium that infects the stomach lining and has been associated with ITP in some populations.
• Other autoimmune diseases — such as systemic lupus erythematosus (lupus), an autoimmune disease that can affect many organs, or antiphospholipid syndrome.
• Certain medications — some drugs can trigger immune reactions against platelets; this is usually considered a separate, drug-induced thrombocytopenia, but the picture can overlap with ITP.
• Some blood cancers — conditions such as chronic lymphocytic leukemia or lymphoma can occasionally be accompanied by immune-mediated platelet destruction.
• Recent vaccination — rarely, ITP has been reported after certain vaccines, particularly in children; this is uncommon, and vaccination remains recommended for most people according to their doctor’s advice.

Risk factors include age and sex. Childhood ITP most often affects young children and usually resolves on its own. Among younger and middle-aged adults, ITP is somewhat more common in women, while in older adults it affects men and women more evenly. Pregnancy can also be associated with low platelet counts, and doctors must carefully distinguish ITP from other pregnancy-related causes. Importantly, ITP is not caused by anything a person did, it cannot be spread to others, and in most cases it is not inherited.

Diagnosis

There is no single test that proves a person has ITP. Instead, immune thrombocytopenic purpura diagnosis is a “diagnosis of exclusion,” which means doctors confirm a low platelet count and then rule out other conditions that can cause it. The evaluation is usually led by a hematologist, a doctor who specializes in blood disorders.

The diagnostic process typically includes:

• Medical history and physical examination — the doctor asks about bleeding symptoms, recent infections, medications, alcohol use, family history, and other illnesses, and examines the skin, mouth, lymph nodes, and abdomen. In ITP, the spleen is usually normal in size; a clearly enlarged spleen suggests the doctor should look for another cause.
• Complete blood count (CBC) — a routine blood test that measures platelets, red blood cells, and white blood cells. In ITP, the platelet count is low while the other cell counts are usually normal.
• Peripheral blood smear — a drop of blood is examined under a microscope to check that the platelets and other blood cells look normal in shape and that the low count is not a laboratory artifact, such as platelets clumping together in the test tube.
• Additional blood tests — depending on the situation, doctors may test for HIV, hepatitis C, Helicobacter pylori, thyroid problems, liver function, or markers of other autoimmune diseases, since these can cause or accompany a low platelet count.
• Bone marrow examination — a sample of bone marrow is taken, usually from the hip bone, under local anesthesia. This test is not needed for most patients but may be recommended when the picture is unusual, when other blood counts are abnormal, when the person is older, or when treatment does not work as expected.

Tests for antiplatelet antibodies exist but are not reliable enough to confirm or exclude ITP on their own, so they are not part of routine diagnosis. Imaging studies such as ultrasound are not required to diagnose ITP but may occasionally be used to assess the spleen or investigate other findings. Doctors generally consider ITP when the platelet count falls below a defined threshold and no other explanation — such as medication effects, liver disease, pregnancy-related changes, infections, or bone marrow disorders — accounts for it.

Treatment options for immune thrombocytopenic purpura

Immune thrombocytopenic purpura treatment depends on the platelet count, the severity of bleeding, the person’s age and lifestyle, and whether the condition is newly diagnosed or chronic. The main goal of treatment is not to make the platelet count perfectly normal, but to keep it at a level that prevents significant bleeding. Care is typically coordinated by a hematology team; at Acibadem, for example, this condition is managed within the Hematology Department.

Watchful waiting

Not everyone with ITP needs immediate treatment. If the platelet count is only mildly or moderately reduced and there is little or no bleeding, doctors often recommend careful observation with regular blood tests. This is especially common in children, in whom ITP frequently resolves on its own within weeks to months. During observation, patients are usually advised to avoid activities with a high risk of injury and to avoid medications that interfere with platelet function, such as aspirin and nonsteroidal anti-inflammatory drugs (a group of common painkillers that includes ibuprofen), unless a doctor advises otherwise.

First-line medications

When treatment is needed, corticosteroids — anti-inflammatory medicines such as prednisone or dexamethasone — are usually the first choice. They calm the immune attack on platelets and often raise the platelet count within days to weeks. Because long-term steroid use can cause side effects such as weight gain, mood changes, high blood sugar, and bone thinning, doctors generally aim to use the lowest effective dose for the shortest necessary time.

Intravenous immunoglobulin (IVIG), a preparation of antibodies given through a vein, can raise the platelet count quickly and is often used when a rapid rise is needed, for example before surgery or when bleeding is significant. Its effect is usually temporary. A related option, anti-D immunoglobulin, may be considered in selected patients with a specific blood type who have not had their spleen removed.

Second-line medications

If ITP does not respond to first-line treatment, or returns when steroids are reduced, other options may be considered:

• Thrombopoietin receptor agonists — medicines such as eltrombopag or romiplostim that stimulate the bone marrow to make more platelets rather than blocking their destruction. They are taken as tablets or injections and often require ongoing use.
• Rituximab — an antibody medicine that reduces the immune cells producing the antiplatelet antibodies. It can produce lasting responses in some people, although the effect may wear off over time.
• Other immune-modulating drugs — several additional medicines that dampen the immune system may be used in selected cases, based on the individual’s situation and the hematologist’s judgment.

Splenectomy (surgery)

Splenectomy is the surgical removal of the spleen, the main organ where antibody-coated platelets are destroyed. It can produce long-lasting remission in many patients with chronic ITP, but it is generally reserved for people who have not responded to medications, and doctors often prefer to wait at least a year after diagnosis because some cases improve on their own. Living without a spleen increases the lifelong risk of certain serious infections, so patients are usually given specific vaccinations before surgery and advised about prompt treatment of fevers afterward.

Emergency treatment

When serious bleeding occurs, doctors may combine several treatments at once — such as corticosteroids, IVIG, and platelet transfusions — to raise the platelet count as quickly as possible. Platelet transfusions are not a routine treatment for ITP, because transfused platelets are destroyed quickly by the same immune process, but they can be lifesaving in an emergency.

Living with immune thrombocytopenic purpura and outlook

The outlook for ITP is generally reassuring, though it varies by age and course. In most children, the condition resolves within a few months, often without any treatment, and does not return. In adults, ITP is more likely to become chronic; even so, many adults maintain a safe platelet count with little or no ongoing treatment, and serious bleeding is uncommon with appropriate monitoring. Some people experience remissions and relapses over the years, which is why regular follow-up with a hematology team is important. No doctor can guarantee a particular outcome, but with modern treatment options, most people with ITP can expect to lead full, active lives.

Practical steps that many patients find helpful include:

• Attending scheduled blood tests and follow-up visits, even when feeling well, because the platelet count can change without obvious symptoms.
• Checking with a doctor or pharmacist before taking new medications or supplements, since some — including aspirin, ibuprofen, and certain herbal products — can affect platelet function or interact with ITP treatments.
• Discussing sports and physical activity with the care team; gentle exercise is usually encouraged, while contact sports may need to be limited when the platelet count is very low.
• Telling dentists, surgeons, and other healthcare providers about the diagnosis before any procedure.
• Limiting alcohol, which can affect platelets and the bone marrow.
• Seeking support for the emotional side of a chronic condition; fatigue and anxiety are common and worth discussing openly with the care team.

Women with ITP who are pregnant or planning pregnancy should be followed jointly by a hematologist and an obstetrician, as platelet counts can shift during pregnancy and around delivery. In most cases, pregnancy can proceed safely with appropriate monitoring and planning.

Frequently asked questions

What is immune thrombocytopenic purpura in simple terms?

It is an autoimmune condition in which the immune system destroys platelets, the blood cells that help stop bleeding. With fewer platelets, a person may bruise easily, develop small red or purple spots on the skin, or bleed longer than usual. It is not contagious and is not a cancer, and many people with the condition live normal, active lives with monitoring or treatment.

Can immune thrombocytopenic purpura go away on its own?

In many children, yes — the condition often resolves within a few months without treatment, especially when it follows a viral infection. In adults it is more likely to persist and become chronic, although spontaneous improvement can still happen. Because the course varies from person to person, doctors usually recommend regular blood tests rather than assuming the condition has resolved.

How serious is immune thrombocytopenic purpura?

The seriousness depends mainly on the platelet count and the bleeding symptoms a person actually has. Many people have only mild bruising or no symptoms at all. Severe internal bleeding, including bleeding in the brain, is uncommon but is the most dangerous complication and is more likely when the platelet count is very low. This is why doctors monitor the condition and treat it when the risk of bleeding becomes significant.

What triggers immune thrombocytopenic purpura?

Often no specific trigger is found; this is called primary ITP. In other cases, the condition is associated with viral infections, Helicobacter pylori infection, other autoimmune diseases such as lupus, certain medications, or some blood disorders. In children, ITP frequently appears shortly after a common viral illness. It is not caused by diet, stress, or anything the person did wrong.

How is immune thrombocytopenic purpura diagnosed?

Doctors confirm a low platelet count with a complete blood count and examine the blood under a microscope, then rule out other causes of low platelets, such as medications, infections, liver disease, or bone marrow problems. There is no single confirmatory test, so the diagnosis is made by exclusion. A bone marrow examination is only needed in selected situations, for example when other blood counts are abnormal or treatment does not work as expected.

Is immune thrombocytopenic purpura curable?

There is no treatment that reliably cures ITP in every person, but long-lasting remission is possible. Many children recover completely, and in adults, treatments such as corticosteroids, rituximab, or splenectomy lead to durable remission in a proportion of patients, while other medicines can keep the platelet count at a safe level long term. Your doctor can explain which options fit your situation and what results are realistic to expect.

Can I live a normal life with chronic ITP?

In many cases, yes. People with chronic ITP often work, travel, exercise, and raise families with few restrictions, provided the platelet count is monitored and kept at a safe level. Adjustments may include avoiding certain painkillers, limiting high-impact contact sports during periods of very low counts, and informing healthcare providers about the condition before procedures. Ongoing follow-up with a hematology team helps catch changes early.

When to see a doctor

Anyone who notices unexplained bruising, pinpoint red or purple spots on the skin, or bleeding that is unusually frequent or hard to stop should arrange a medical evaluation. People already diagnosed with ITP should keep their scheduled follow-up visits and contact their care team if symptoms change or worsen.

Seek urgent or emergency medical care if any of the following occur, as they may signal dangerous bleeding:

• A severe or sudden headache, confusion, drowsiness, weakness on one side of the body, vision changes, or a seizure — possible signs of bleeding inside the skull.
• Bleeding that will not stop after applying steady pressure for a prolonged period, including a nosebleed lasting more than about 20 to 30 minutes.
• Vomiting blood or vomit that looks like coffee grounds.
• Blood in the urine, or stool that is bloody, black, or tarry.
• Very heavy menstrual bleeding, such as soaking through pads or tampons every hour for several hours.
• Rapidly spreading bruises or blood blisters in the mouth, especially together with new petechiae appearing over hours.
• A significant head injury or major trauma, even if you feel well afterward, because a low platelet count increases the risk of internal bleeding.

These warning signs do not mean serious bleeding is certain, but they should always be assessed promptly by a medical professional. Early evaluation allows doctors to check the platelet count and treat any bleeding before it becomes dangerous.